DelveInsight’s “Hypothyroidism Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Hypothyroidism, historical and forecasted epidemiology as well as the Hypothyroidism market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Hypothyroidism Overview
Hypothyroidism, or underactive thyroid, happens when your thyroid gland doesn’t make enough thyroid hormones to meet your body’s needs. Your thyroid is a small, butterfly-shaped gland in the front of your neck. It makes hormones that control the way the body uses energy.
Thyroid hormones regulate your body’s metabolism and temperature; when a deficiency occurs, your body has trouble using energy and staying warm. Common symptoms include fatigue, coldness, constipation, and slight weight gain.
Hypothyroidism Epidemiology Insights
Hypothyroidism affects up to 5% of the general population, with a further estimated 5% being undiagnosed. Over 99% of affected patients suffer from primary hypothyroidism
The overall incidence of hyperthyroidism is estimated between 0.05% and 1.3%, with the majority comprising subclinical disease. A population-based study in the United Kingdom and Ireland found an incidence of 0.9 cases per 100,000 children younger than 15 years, showing that the disease incidence increases with age
Click here to learn more about the Hypothyroidism Market Landscape
The Report Covers the Hypothyroidism Epidemiology Segmented by:
Hypothyroidism prevalent cases
Hypothyroidism diagnosed cases
Hypothyroidism treatment cases
Hypothyroidism incident cases
Hypothyroidism cases based on age
Hypothyroidism Market Outlook
The Hypothyroidism market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Hypothyroidism market trends by analyzing the impact of current Hypothyroidism therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Hypothyroidism market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Hypothyroidism market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Hypothyroidism market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Hypothyroidism Market
Abbott
Bayer
Merck
Takeda
Celgene
GlaxoSmithKline
And many others
Key Therapies in the Hypothyroidism Market
Iohexol
Iodixanol
Iopromide
Ioversol
ST-1891
Revlimid
Learn more about the Key Companies and Emerging Therapies in the Hypothyroidism Market
Table of Contents
Key Insights
Hypothyroidism Introduction
Executive Summary of Hypothyroidism
Disease Background and Overview
Epidemiology and patient population
Hypothyroidism Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Hypothyroidism Market Outlook.
Media ContactCompany Name: DelveInsight Business ResearchContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting